[1]
Garlatti Costa, E., Ghersetti, M., Grazioli, S. and Casarin, P. 2015. Efficacy of dual therapy in patients >65 years old with alanine transaminase flare during chronic hepatitis C genotype 2. Italian Journal of Medicine. 9, 1 (Mar. 2015), 82–88. DOI:https://doi.org/10.4081/itjm.2015.471.